The Promise of NextGen MURR

By Blaine Luetkemeyer, 3rd District Congressman
Posted 11/6/24

For so many of us, cancer isn’t just a word—it’s personal.   Whether it’s touched a friend, family member, or even ourselves, cancer has left its mark on our lives and …

This item is available in full to subscribers.

Please log in to continue

E-mail
Password
Log in

The Promise of NextGen MURR

Posted

For so many of us, cancer isn’t just a word—it’s personal.  Whether it’s touched a friend, family member, or even ourselves, cancer has left its mark on our lives and our communities. It’s a fight that impacts not only our loved ones but also our entire nation. But here in the Third District, we are leading the charge in the fight against this devastating disease. With each passing day, research and treatment options are advancing, and I’m proud to say that Missouri is at the forefront of that progress.

Over the past 15 years, I’ve been an avid supporter of funding the nuclear reactor at the University of Missouri. This isn’t just about funding a reactor; it’s about powering life-saving discoveries. The NextGen MURR project will bring a new, 20-megawatt state-of-the-art research reactor to Mizzou, expanding critical medical isotope research and production for cancer treatments. These are the technologies that make a real difference in the lives of cancer patients—technologies that come from uranium, cobalt, and rare earth elements, which are the backbone of nuclear reactors and the radiopharmaceuticals they produce. NextGEN MURR builds on the legacy of the existing MURR facility, the only U.S. producer of four essential medical isotopes used to treat liver, thyroid, pancreatic, and prostate cancers.  This new reactor will allow Missouri to remain a global leader in the development of radiopharmaceuticals, strengthening our role in research that will impact healthcare nationwide.

This couldn’t have come at a more crucial moment. As the demand for critical minerals essential for lifesaving treatments is projected to surge by over 20% in the next decade—largely fueled by the increasing need for cancer therapies that rely on isotopes—NextGEN MURR is perfectly positioned to meet this challenge. Currently, MURR is already making significant contributions to healthcare, generating billions through enhanced diagnostics and treatment. With the development of NextGEN MURR, we have the potential to elevate that impact to an astounding $3 billion annually.

I began supporting the research reactor at the University of Missouri because I believed in its potential to change lives right here in the Third District. Supporting Missouri-based research has always been an easy decision for me—not just for the research dollars, but for positioning Missouri as a hub for innovation. Today, we’re seeing that vision realized as MURR leads groundbreaking work that’s saving lives and advancing cancer treatment. But this is just the beginning. As NextGEN MURR propels us into the next 15 years, driving new discoveries in nuclear research, medical treatments, and technological advancements that will directly benefit our district and our nation, its impact will extend far beyond the lab. It will create high-skilled jobs, boost our local economy, and ensuring more families in our community have access to cutting-edge treatments.

I’ll leave you with this - I can assure you that the future of the Third District is bright as we lead the nation in nuclear research and medical technology, offering real hope in the fight against cancer. Our investment today is more than just a financial commitment; it’s a promise to future generations to come. 

CONTACT US: I encourage you to visit my official website or call my offices in Jefferson City (573-635-7232) or Cottleville (636-327-7055) with your questions and concerns. If you want even greater access to what I am working on, please visit my YouTube site, Facebook page, and keep up-to-date with Twitter and Instagram.